Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Paula Arranz"'
1
Akademický článek
Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions
Autor: Manuel Román, Dolores Ochoa, Samuel Martin, Sergio Luquero, Inmaculada Gilaberte, Paula Arranz, Carlos Sánchez
Publikováno v: Drugs in R&D, Vol 24, Iss 3, Pp 405-414 (2024)
Abstract Background and Objective Orodispersible tablets (ODT) rapidly dissolve in the oral cavity and can improve patient’s convenience. This pharmacokinetic study assessed the bioequivalence of a novel 20 mg ODT formulation of bilastine compared
Externí odkaz: https://doaj.org/article/1c3d86a85d004269be0b3fc795dea5f0
Zobrazit plný text záznamu
2
Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study
Autor: Piotr Kuna, Marek Jutel, Grazyna Pulka, Slawomir Tokarski, Paula Arranz, Gonzalo Hernández, Nieves Fernández Hernando
Publikováno v: Clinical Ophthalmology.
Piotr Kuna,1 Marek Jutel,2,3 Grazyna Pulka,4 Slawomir Tokarski,5 Paula Arranz,6 Gonzalo Hernández,6 Nieves Fernández Hernando6 1Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland; 2Department of Clinic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f337975594a0a254a8008d6a480e712
https://www.dovepress.com/safety-and-tolerability-of-bilastine-06-ophthalmic-solution-an-8-weeks-peer-reviewed-fulltext-article-OPTH
Zobrazit plný text záznamu
3
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Autor: Lorena Elgezabal, Nieves Fernandez, Paula Arranz, Carmen Belmonte, Samuel Martín-Vílchez, Francisco Abad-Santos, Gina Mejía-Abril, Manuel Román, Gonzalo Hernández, Dolores Ochoa
Publikováno v: Advances in Therapy
Introduction Bilastine is a second-generation H1 antihistamine indicated for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. On the basis of the demonstrated efficacy and safety of the oral formulation, a new ophthalmic formu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::958009d8415f9c7ab155036461ecbf23
http://europepmc.org/articles/PMC8280016
Zobrazit plný text záznamu
4
Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial
Autor: Laura Gallego López, Roger Bouillon, Sandra P. Chinchilla, Bernat Galarraga, Gonzalo Hernández-Herrero, José Manuel Quesada-Gómez, Esteban Jódar, Maria Luisa Brandi, José Luis Pérez-Castrillón, Carlos Gómez-Alonso, Nieves Fernández-Hernando, Javier del Pino-Montes, Jesús González-Macías, Paula Arranz-Gutiérrez, Fernando Cereto Castro, María Rosa Alhambra Expósito, José Manuel Olmos Martínez, Antonio Dueñas-Laita
Publikováno v: Journal of Bone and Mineral Research
J Bone Miner Res . 2021 Oct;36(10):1967-1978
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Vitamin D has shown to play a role in multiple diseases due to its skeletal and extraskeletal actions. Furthermore, vitamin D deficiency has become a worldwide health issue. Few supplementation guidelines mention calcifediol treatment, despite being
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd8edeab786a5dbf73b37b4622ddb97e
http://europepmc.org/articles/PMC8597097
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje